sábado, 31 de agosto de 2019

Statement from Acting FDA Commissioner Ned Sharpless, M.D., and CDC Director Robert R. Redfield, M.D., on federal and state collaboration to investigate respiratory illnesses reported after use of e-cigarette products



Statement from Acting FDA Commissioner Ned Sharpless, M.D., and CDC Director Robert R. Redfield, M.D., on federal and state collaboration to investigate respiratory illnesses reported after use of e-cigarette products

Both the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention are working tirelessly to investigate the distressing incidents of severe respiratory disease associated with use of e-cigarette products. We were deeply saddened last week to learn of the death of an adult in Illinois who had been hospitalized with a severe respiratory illness following the use of an e-cigarette product. We are working closely with state and local health officials to investigate these incidents as quickly as possible, and we are committed to taking appropriate actions as a clearer picture of the facts emerges. 

No hay comentarios: